MedTrace Logo

Evaluation of Inflammatory Cytokines During COVID-19

NCT04824495 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-04-06

No results posted yet for this study

Summary

The aim of this study is to evaluate pro-inflammatory cytokines as well as microvesicles during the course of SARS-CoV2 infection in the context of clinical parameters.

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

Blood sample

Blood samples at different timepoints during SARS-CoV2 infection

Sponsors & Collaborators

  • University of Vienna

    lead OTHER

Principal Investigators

  • Daniela Gompelmann · Medical University of Vienna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-07
Primary Completion
2021-08-31
Completion
2021-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04824495 on ClinicalTrials.gov